Basic Efudix Information

• INN (International Nonproprietary Name): Fluorouracil
• Brand names available in United Kingdom: Efudix; fluorouracil generic products may also be supplied through UK prescription channels
• ATC Code: D06BB03
• Forms & dosages: Topical cream 5% in tubes of 20g, 40g, or 50g; topical solution 2% or 5% in bottles of 10mL, 25mL, or 30mL
• Manufacturers in United Kingdom: Meda AB (Mylan/Viatris), Teva, and Sandoz are listed among European suppliers; UK supply follows prescription pharmacy channels
• Registration status in United Kingdom: Prescription-only medicine; no recognised OTC formulation
• OTC / Rx classification: Prescription (Rx) only, not OTC

Ever been told that a sore, red patch on the face or scalp is “just sun damage”, yet it keeps coming back?

That is exactly the sort of situation where Efudix often comes up in UK dermatology and pharmacy conversations.

Efudix is the familiar European and UK brand name for fluorouracil cream, a topical chemotherapy used mainly for actinic keratoses treatment and, in selected cases, superficial basal cell carcinoma.

It is not a cosmetic cream and it is not a quick fix.

It is a prescription treatment designed to clear abnormal sun-damaged cells from the surface of the skin.

For many UK patients, that means a short but uncomfortable course that can help prevent bigger problems later.

Recent Trial Findings

What do newer studies really say about topical fluorouracil in 2022 to 2025?

The direction of travel has been fairly consistent.

Topical fluorouracil remains a high-value option for actinic keratoses and selected superficial basal cell carcinoma, particularly when lesion burden is broad rather than isolated.

That matters because field therapy treats the whole sun-damaged area, not just the spots that are easy to see.

Recent dermatologic oncology trial trends continue to support this field approach, especially on the face, scalp, and forearms where sun damage is often patchy and widespread.

Compared with imiquimod, diclofenac gel, and some newer or less commonly used field approaches, fluorouracil cream tends to stand out for strong clearance rates and a long clinical track record.

In routine dermatology, that combination is still important because cost-effectiveness matters in the UK as much as efficacy.

Patients and clinicians often accept a more intense local reaction if the overall clearance is better and the treatment remains practical.

That is also why Efudix and other fluorouracil cream products continue to be widely searched and prescribed.

Common outcome measures in recent work include lesion clearance, control of field cancerisation, recurrence reduction, and whether patients can stick with the full course.

Adherence is a real-world issue.

Some people stop too early because the skin gets inflamed and they think the medicine is harming them rather than working.

That is usually a misunderstanding.

With topical fluorouracil, redness and crusting are expected signs that damaged keratinocytes are being targeted.

Serious systemic toxicity is rare with topical use, but it is not something to ignore entirely.

Dihydropyrimidine dehydrogenase deficiency is the major safety consideration because it can increase systemic exposure and raise risk.

How Efudix Works

What is actually happening when the cream makes the skin red and sore?

Efudix is a prescription cream that targets damaged, sun-exposed skin cells at the surface.

It helps the body remove precancerous cells that would otherwise keep spreading across the treated area.

Fluorouracil topical treatment belongs to the antimetabolite group and acts as a pyrimidine analogue.

In plain English, it interferes with DNA synthesis in cells that are dividing too quickly or behaving abnormally.

The key enzyme involved is thymidylate synthase.

By interfering with that pathway, fluorouracil reduces DNA replication and makes dysplastic tissue less able to survive.

Damaged keratinocytes are affected more than normal skin cells, which is why the treated area becomes inflamed.

That inflammatory response is part of the mechanism, not a sign that the treatment has failed.

As the abnormal cells die off, the skin clears in stages.

First there is irritation, then erosion or crusting, and finally healing once treatment stops.

That is the classic field therapy pattern seen with fluorouracil cream and similar topical chemotherapy.

From a dermatology point of view, the aim is cellular clearance of abnormal keratinocytes rather than simply calming the surface.

Approved And Off-Label Use

Is Efudix only for actinic keratoses, or does it have other uses too?

In the UK, Efudix is the better-known brand name for fluorouracil cream used under prescription.

Its established uses include actinic keratosis and, in selected cases, superficial basal cell carcinoma.

It is prescription-only, and there is no recognised OTC formulation.

That Rx-only status matters because the cream needs proper counselling, especially when patients are starting treatment on the face or scalp.

Broader field treatment of sun-damaged skin is a common specialist-led approach.

Dermatologists may use fluorouracil 5% cream over the face, scalp, or forearms when the burden of sun damage is widespread.

Combination regimens are also used in some clinics, although those should always be clinician-led rather than self-directed.

For UK searches, people often look for “Efudix 5% cream”, “fluorouracil cream UK”, or “prescription fluorouracil cream”.

Those search terms usually reflect the same thing: a treatment for visible sun damage that needs medical supervision.

In our online pharmacy, efudix is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

That access point can help some patients manage supply quickly, but it should still be used with the right treatment advice and safety checks.

How It Is Dosed

How much cream is used, and how long should treatment continue?

The usual regimen is a thin film applied twice daily, morning and evening.

That basic approach is the same for most standard uses of fluorouracil 5% cream.

Treatment is typically continued until a sufficient inflammatory response develops, rather than stopping as soon as the area looks red.

For actinic keratosis, the usual course is 2 to 4 weeks.

For superficial basal cell carcinoma, treatment is usually 3 to 6 weeks and can sometimes continue for up to 12 weeks.

The target is eradication of the lesion or field, not simply softening the skin surface.

Children are not established-use candidates because safety and efficacy have not been established.

Older adults do not usually need a routine dose change, but they should be monitored carefully for adverse effects.

No formal dose adjustment is recommended for renal or hepatic impairment, although caution is sensible because toxicity may be harder to predict.

Missed doses should be applied as soon as possible, unless it is nearly time for the next dose.

Doubling up is not advised.

That can increase irritation without improving outcomes.

Safety And Side Effects

Should patients be worried when the skin burns or peels?

Some discomfort is expected with fluorouracil topical treatment.

Typical effects include burning, stinging, redness, scaling, dryness, erosion, ulceration, and increased photosensitivity.

The phrase “expected local reaction” is important here.

For many patients, the skin becoming inflamed is a marker that the cream is doing its job.

That said, treatment must be reviewed if the reaction becomes extensive, very painful, infected, or starts to look systemic.

Serious systemic toxicity is rare with topical use, but it can happen, especially in higher-risk patients.

Dihydropyrimidine dehydrogenase deficiency is a major relative contraindication because it can raise the systemic risk.

Other situations that call for close monitoring include immunocompromised patients and anyone with a history of severe local reactions to topical chemotherapy.

Absolute contraindications include allergy to fluorouracil or excipients, pregnancy, breastfeeding, and application to open wounds, mucous membranes, or eyes.

UV avoidance is essential during treatment.

Skin that is already inflamed is more vulnerable to sunburn and further irritation.

Severe inflammation and secondary infection are rare but need prompt review.

Interactions And Practical Precautions

Can patients use their usual moisturiser, cleanser, or other treatments alongside Efudix?

No meaningful food interactions are expected with topical fluorouracil.

The main cautions are skin-care related rather than diet related.

Other irritating topical products should not be layered onto the same area unless a clinician has said it is appropriate.

That includes exfoliants, retinoids, acids, and harsh cleansers.

These can add to the irritation and make the course much harder to tolerate.

Occlusive overuse should also be avoided unless specifically advised.

Putting on more cream or covering the area too aggressively does not make treatment work faster.

It often just increases inflammation.

Sun exposure should be minimised throughout the course.

Extra care is sensible in patients on immunosuppressive therapy or anyone treating a large skin field.

Those patients may have a different tolerance profile and should be followed more closely.

What Patients Usually Experience

What does a normal treatment course feel like in real life?

Most patients describe a visible inflammatory phase that can be uncomfortable and a bit draining.

Burning sensation, redness, crusting, and treatment fatigue are all common themes.

Some people also worry about how they will look while using the cream, particularly when treating the face.

That concern is understandable.

It is one reason adherence improves when patients are told in advance that redness and crusting are expected.

In practice, people often tolerate the course better when they know the reaction is part of the plan.

Forum-style discussions usually circle around the same points: the treatment stings, it looks dramatic, and it can be socially inconvenient.

At the same time, many patients like the sense that they are doing something active about sun-damaged skin.

That is especially true for people who have already had several actinic keratoses or who have been told they have field cancerisation.

UK patients often search for “Efudix for sun-damaged skin” or “Efudix cream 5%” before starting.

Those searches usually reflect a mix of anxiety and determination.

They want to know whether the treatment is worth the short-term discomfort, and the answer is often yes when the area of disease is broad.

Availability And Pricing

Where does Efudix sit in the wider market?

Efudix is the familiar brand in Europe, Australia, and Romania, while the United States uses Efudex and related brands such as Carac, Fluoroplex, and Tolak.

Generic fluorouracil creams and solutions are also widely available.

That means the same active ingredient can appear in different packaging depending on the country and supplier.

Common 5% cream packs are tubes of 20g, 40g, or 50g.

Topical solution comes in 10mL, 25mL, or 30mL bottles at 2% or 5% strengths.

Manufacturers vary by region.

Examples include Meda AB, Viatris, Teva, Sandoz, iNova Pharmaceuticals, Valeant Pharmaceuticals, and Taro Pharmaceuticals.

In the UK, supply usually runs through prescription pharmacy channels rather than OTC retail.

That is the practical reality for patients looking for “Efudix Tub 20g” or “fluorouracil topical”.

Pricing and availability can vary with the supplier, but the medicine is widely recognised as a cost-effective topical chemotherapy option for actinic keratoses treatment.

Its broad use and generic adoption are a big reason it remains such a common choice in dermatology.

Alternative Treatment Options

What if a patient cannot tolerate Efudix, or the clinician wants another approach?

Several alternatives are used for actinic keratosis and related sun-damage problems.

Imiquimod, sold as Aldara, is one of the main comparators and is also used for actinic keratosis and superficial BCC.

Diclofenac gel, sold as Solaraze, is another option for actinic keratosis, usually with a milder irritation profile but often a different pace of response.

Ingenol mebutate, historically known as Picato, is still sometimes mentioned in comparisons, although its role has changed over time.

There are also fluorouracil-based alternatives such as Carac and Tolak, which use different bases but the same active ingredient class.

Efudix has a strong clinical track record, broad field treatment utility, and good cost-effectiveness.

Its downside is the more intense local reaction and the longer period when the skin looks visibly inflamed.

Choice usually depends on lesion burden, body site, patient preference, tolerance for inflammation, and clinician experience.

That is why two patients with the same diagnosis may end up on different creams.

One may need a gentler option, while another is happy to accept a more reactive course for stronger clearance.

Regulatory Status

Is fluorouracil topical legal to buy without a prescription?

No.

Topical fluorouracil is prescription-only and not OTC.

That applies in the UK and in most other markets.

The FDA in the United States has approved it for actinic keratosis and superficial basal cell carcinoma.

In the EU, it is available as Efudix and generics for skin neoplasias.

The TGA has it registered in Australia as Efudix cream.

Romania lists Efudix 5% cream through ANMDMR registration.

The ATC code is D06BB03.

That places it in dermatological antineoplastic and chemotherapeutic topical agents.

The legal and regulatory takeaway is simple.

UK readers should expect prescriber oversight and pharmacy counselling rather than self-selection from an open shelf.

That protects patients from avoidable harm and keeps treatment aligned with the diagnosis.

Common Questions

What is Efudex or Efudix?

It is the brand name for fluorouracil cream, a prescription topical chemotherapy used on sun-damaged skin.

What conditions does fluorouracil cream treat?

It is used mainly for actinic keratoses and, in selected cases, superficial basal cell carcinoma.

How long does treatment usually last?

Actinic keratosis treatment usually lasts 2 to 4 weeks, while superficial basal cell carcinoma may need 3 to 6 weeks and sometimes up to 12 weeks.

Why does the skin get red and sore?

Because fluorouracil targets rapidly dividing abnormal keratinocytes, and the inflammatory response is part of the intended effect.

Is it safe in pregnancy or breastfeeding?

No, it is contraindicated in pregnancy and breastfeeding.

What if a dose is missed?

Apply it as soon as possible, skip it if the next dose is nearly due, and do not double up.

Can children use it?

Safety and efficacy are not established in children, so it should only be used if the benefit clearly justifies the risk.

When should treatment be stopped and reviewed?

Stop and seek medical advice if the reaction becomes severe, spreads beyond the treated field, seems infected, affects the eyes, or becomes systemically unwell.

What Treatment Usually Looks Like

What should patients expect to see day by day?

The usual pattern starts with erythema, then scaling and crusting, then erosion in the treated area, and finally healing after treatment stops.

That sequence can look alarming the first time, especially on the face.

Visible inflammation is usually part of the intended response, not a sign that something has gone wrong.

Patients often find it helpful to think of the course as a timed field therapy rather than a simple moisturising routine.

A basic before-and-after timeline can be reassuring because it shows that the skin often looks worse before it looks better.

An application map can also help when treating the face, scalp, or forearms so the cream stays on the right field and off healthy skin.

A “normal reaction versus urgent review” graphic is useful too.

Signs that need review include spreading inflammation, severe pain, infection, eye exposure, or ulceration beyond the treated field.

Storage And Transport

How should Efudix be kept at home or when travelling?

Store it at room temperature.

Keep it protected from excessive heat and light.

Do not freeze it.

Always keep it in the original container.

That matters because temperature swings can be an issue, especially during travel or summer heat.

A tube left in a car, near a radiator, or in direct sunlight is not being stored properly.

The cap should be kept tightly closed, and the product must be kept out of reach of children.

Good pharmacy advice should include travel dispensing and home storage reminders, particularly when people are starting treatment in warmer months.

How To Use Efudix Properly

What is the safest way to apply the cream?

Apply a thin film to the affected area only, usually twice daily.

Wash hands before and after use unless the hands themselves are being treated.

Avoid the eyes, lips, nostrils, genitals, mucous membranes, and broken skin unless specifically instructed otherwise.

Follow the prescribed duration even if the area becomes inflamed early.

Do not use extra cream to speed things up.

That is one of the most common mistakes patients make when they are anxious to “get it over with”.

More cream does not mean better results.

It usually means more irritation.

Monitoring and follow-up are important if the reaction becomes severe, if infection is suspected, or if lesions persist after the course.

Superficial basal cell carcinoma should always be followed up by a clinician, because response needs proper review.

The main rule is simple: thin layer, right area, right duration, and no doubling of missed doses.

Delivery Across United Kingdom